Literature DB >> 19018290

UNTREATED TRANSIENT LONGER THAN 7-DAY CHAT, CIRCADIAN HYPER-AMPLITUDE TENSION, IN A 7-YEAR PERSPECTIVE.

O Schwartzkopff1, G Cornélissen, C Halpin, G Katinas, J Siegelová, B Fišer, J Dušek, F Halberg.   

Abstract

The case report presented herein aims at promoting the awareness in medical, notably cardiological, practice of the importance of, first, collecting at least a week-long record of around-the-clock measurements of blood pressure (BP) and heart rate (HR) (and a much longer record if the 7 day record so indicates) and, second, of analysing the data chronobiologically in the light of reference values specified as a function of time, gender and age as a minimum. In addition to diagnosing deviations in a chronome (time structure)-adjusted mean value, a chronobiological approach identifies abnormalities in the variability of BP and/or HR, gauged by the circadian characteristics (double amplitude and acrophase, measures of the extent and timing of predictable change within a cycle) and by the standard deviation. A woman in presumably good health was 60 years of age at the start of intermittent monitoring over a 7 year span. The case report illustrates the extent to which a decision based on single BP readings and even on 24 hour averages may be misleading. Treatment based on an initial week-long monitoring may benefit from continued long-term monitoring.

Entities:  

Year:  2005        PMID: 19018290      PMCID: PMC2583359     

Source DB:  PubMed          Journal:  Scr Med (Brno)        ISSN: 1211-3395


  9 in total

1.  7-day ambulatory monitoring for adults with hypertension and diabetes.

Authors:  G Cornélissen; O Schwartzkopff; F Halberg; K Otsuka; Y Watanabe
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

Review 2.  Chronomes, time structures, for chronobioengineering for "a full life".

Authors:  G Cornélissen; F Halberg; O Schwartzkopff; P Delmore; G Katinas; D Hunter; B Tarquini; R Tarquini; F Perfetto; Y Watanabe; K Otsuka
Journal:  Biomed Instrum Technol       Date:  1999 Mar-Apr

3.  Individual assessment of antihypertensive response by self-starting cumulative sums.

Authors:  G Cornélissen; F Halberg; D Hawkins; K Otsuka; W Henke
Journal:  J Med Eng Technol       Date:  1997 May-Aug

4.  The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique.

Authors:  Y Imai; S Sasaki; N Minami; M Munakata; J Hashimoto; H Sakuma; M Sakuma; N Watanabe; K Imai; H Sekino
Journal:  Am J Hypertens       Date:  1992-10       Impact factor: 2.689

Review 5.  Impeachment of casual blood pressure measurements and the fixed limits for their interpretation and chronobiologic recommendations.

Authors:  G Cornélissen; F Halberg
Journal:  Ann N Y Acad Sci       Date:  1996-08-15       Impact factor: 5.691

6.  Untenable acceptance of casual systolic/diastolic blood pressure readings below 140/90 mmHg.

Authors:  Y Kumagai; I Kuwajima; Y Suzuki; K Kuramoto; K Otsuka; G Cornélissen; F Halberg
Journal:  Chronobiologia       Date:  1993 Jul-Dec

Review 7.  Clinical relevance of about-yearly changes in blood pressure and the environment.

Authors:  F Halberg; G Cornélissen; E Haus; G Northrup; A Portela; H Wendt; K Otsuka; Y Kumagai; Y Watanabe; R Zaslavskaya
Journal:  Int J Biometeorol       Date:  1996-11       Impact factor: 3.787

Review 8.  100 or 30 years after Janeway or Bartter, Healthwatch helps avoid 'flying blind'.

Authors:  Germaine Cornélissen; Franz Halberg; Earl Bakken; Ram B Singh; Kuniaki Otsuka; Brian Tomlinson; Alain Delcourt; Guy Toussaint; Srilakshmi Bathina; Othild Schwartzkopff; Zhengrong Wang; Roberto Tarquini; Federico Perfetto; Giancarlo Pantaleoni; Rita Jozsa; Patrick A Delmore; Ellis Nolley
Journal:  Biomed Pharmacother       Date:  2004-10       Impact factor: 6.529

9.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.